IRIS
BIANCHI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 81.273
EU - Europa 6.612
AS - Asia 3.787
SA - Sud America 65
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 15
Totale 91.818
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 81.191
SG - Singapore 2.016
IT - Italia 1.576
CN - Cina 1.160
IE - Irlanda 1.128
UA - Ucraina 793
DE - Germania 768
FR - Francia 499
RU - Federazione Russa 418
SE - Svezia 405
GB - Regno Unito 366
KR - Corea 236
FI - Finlandia 224
PL - Polonia 184
IN - India 89
CA - Canada 68
BE - Belgio 58
JP - Giappone 54
UZ - Uzbekistan 43
BR - Brasile 37
NL - Olanda 35
AU - Australia 32
ES - Italia 29
EU - Europa 25
KG - Kirghizistan 25
HK - Hong Kong 22
RO - Romania 21
IL - Israele 19
TR - Turchia 18
CZ - Repubblica Ceca 17
CH - Svizzera 15
MY - Malesia 15
VN - Vietnam 15
AE - Emirati Arabi Uniti 14
SK - Slovacchia (Repubblica Slovacca) 13
AT - Austria 12
ID - Indonesia 12
MX - Messico 12
EG - Egitto 10
PH - Filippine 10
PT - Portogallo 10
IR - Iran 9
PE - Perù 9
HU - Ungheria 8
PK - Pakistan 7
AR - Argentina 6
CL - Cile 6
GR - Grecia 6
TH - Thailandia 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
RS - Serbia 5
HR - Croazia 4
BD - Bangladesh 3
CO - Colombia 3
LT - Lituania 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
BO - Bolivia 2
IQ - Iraq 2
PA - Panama 2
SC - Seychelles 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
EC - Ecuador 1
EE - Estonia 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 91.818
Salva come PNG Salva come JPEG
Città #
Wilmington 23.340
Houston 22.124
Woodbridge 17.468
Fairfield 3.301
Chandler 1.874
Singapore 1.764
Ashburn 1.581
Seattle 1.345
Ann Arbor 1.308
Cambridge 1.216
Dublin 1.029
Medford 743
Jacksonville 635
Dearborn 573
Santa Clara 476
Beijing 429
Rome 409
Lawrence 352
New York 314
Zhengzhou 256
San Diego 223
Menlo Park 207
Kraków 162
Moscow 149
Boardman 111
Redwood City 110
Milan 96
Shanghai 79
Seoul 75
Mülheim 74
London 69
Cedarhurst 65
Norwalk 62
Helsinki 58
Munich 58
Brussels 54
Hefei 49
Nanjing 49
Falls Church 40
San Mateo 40
Engelhard 38
Toronto 36
Guangzhou 34
Los Angeles 32
Esslingen am Neckar 31
Mountain View 31
Nanchang 31
Verona 30
Council Bluffs 28
Kunming 27
Redmond 27
Jinan 26
Nuremberg 26
University Park 25
Detroit 24
Palo Alto 23
Kilburn 21
Atlanta 20
Saint Petersburg 20
Auburn Hills 19
Florence 19
Manitou Springs 19
Naples 19
Perugia 19
Del Norte 18
Trieste 18
Paris 17
Lappeenranta 16
Pune 16
Wuhan 16
Chicago 15
Bari 14
Salt Lake City 14
San Jose 14
Brno 13
Hangzhou 13
Phoenix 13
Torino 13
Dubai 12
Shenyang 12
Chengdu 11
Hounslow 11
Ottawa 11
Palermo 11
Sydney 11
Tokyo 11
Amsterdam 10
Dong Ket 10
Genova 10
Napoli 10
Creede 9
Fuzhou 9
Genazzano 9
Hong Kong 9
Lima 9
Messina 9
The Dalles 9
Dallas 8
Hebei 8
Madrid 8
Totale 83.419
Salva come PNG Salva come JPEG
Nome #
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data 1.601
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.355
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.177
Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions 726
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 710
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 656
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 588
Is weekly dose of adalimumab a simple approach for resistant psoriasis? 520
Efficacy and safety of infliximab in psoriatic patients over the age of 65 500
Leflunomide-induced DRESS syndrome 478
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 477
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 461
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry. 453
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. 446
Angiosarcoma cutaneo epitelioide 444
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. 442
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 433
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 432
Treatment of trachyonychia with tazarotene 428
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 421
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 421
Psodisk, a new visual method for assessing the burden of psoriasis on patients 421
Cheratodermia puntata porocheratosica 421
Treatment of kerion with fluconazole [30] 418
Tazarotene as alternative topical treatment for onychomycosis 417
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 413
Apremilast for the treatment of psoriasis. 412
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 410
Actinic keratosis treated with an immune response modifier: a case report of six patients 408
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 408
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 407
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis 407
Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids 406
Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis 404
Pachydermoperiostosis: Study of epidermal growth factor and steroid receptors 398
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 398
Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis 398
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 397
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 397
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 397
Topical lactoferrin can improve stable psoriatic plaque 396
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 392
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis 391
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 391
Tildrakizumab for treating psoriasis 387
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 387
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 386
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 385
Severe acne successfully treated with etanercept 384
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 384
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 383
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 383
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 382
Stress reactivity in psoriatic patients 381
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 381
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 380
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 380
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 379
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 378
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features 376
Phrynoderma: a cutaneous sign of an inadequate diet 375
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 375
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 370
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections 370
Brodalumab for the treatment of psoriasis 367
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 367
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 366
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients 366
Psoriasiform sarcoidosis: an unusual variety 363
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 362
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 361
Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients. 361
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 360
Quality-of-life impairment in hidradenitis suppurativa 359
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 359
Abnormal bcl-2 and 'tissue' transglutaminase expression in psoriatic skin 358
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 358
Confocal reflectance microscopy in pityriasis rubra pilaris 357
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 357
Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner 356
Mixoma intramuscolare del volto 356
Elementi di dermatologia 354
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 354
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 353
Zosteriform metastasis of occult bronchogenic carcinoma 351
Psodisk, a new visual method for assessing the burden of psoriasis on patients 350
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 350
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 349
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 349
Tofacitinib for the treatment of psoriasis 348
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Design, development, and use in therapy 348
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 348
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 347
Familial occurrence of pseudoxanthoma-elasticum-like papillary dermal elastolysis 346
Tuberous sclerosis with specific renal involvement 344
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis 342
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature 342
Erysipeloid cutaneous metastasis from bladder carcinoma 340
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 340
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 340
Totale 42.810
Salva come PNG Salva come JPEG
Categoria #
all - tutte 214.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019.722 0 0 0 2.203 2.364 2.586 2.300 2.274 2.451 2.145 1.666 1.733
2020/202117.861 1.751 1.818 1.760 2.130 2.426 2.125 2.158 1.880 398 634 502 279
2021/20223.995 205 440 264 180 182 308 314 191 263 316 291 1.041
2022/20235.096 493 586 199 613 459 1.123 425 286 469 77 236 130
2023/20242.300 248 69 139 72 184 425 226 183 53 192 107 402
2024/20253.878 338 2.075 1.146 319 0 0 0 0 0 0 0 0
Totale 94.120